IRCR201 is a bivalent fully-human antibody that binds to the plexin-semaphorin-integrin (PSI) domain of c-Met and exhibits a tumor inhibitory effect by regulating tumor cellular growth, proving to have ideal effects in cancer treatment. The gene discussed is MET; the disease is neoplasm.